BACKGROUND: Variation in platelet reactivity contributes to disorders of hemostasis and thrombosis, but the molecular mechanisms are not well understood. OBJECTIVES: To discover associations between interindividual platelet variability and the responsible platelet genes, and to begin to define the molecular mechanisms altering platelet gene expression. SUBJECTS/ METHODS: Two hundred and eighty-eight healthy subjects were phenotyped for platelet responsiveness. Platelet RNA from subjects demonstrating hyperreactivity (n=18) and hyporeactivity (n=11) was used to screen the human transcriptome. RESULTS: Distinctly different mRNA profiles were observed between subjects with differing platelet reactivity. Increased levels of mRNA for VAMP8/endobrevin, a critical v-SNARE involved in platelet granule secretion, were associated with platelet hyperreactivity (Q=0.0275). Validation studies of microarray results showed 4.8-fold higher mean VAMP8 mRNA levels in hyperreactive than hyporeactive platelets (P=0.0023). VAMP8 protein levels varied 13-fold among platelets from these normal subjects, and were 2.5-fold higher in hyperreactive platelets (P=0.05). Among our cohort of 288 subjects, a VAMP8 single-nucleotide polymorphism (rs1010) was associated with platelet reactivity in an age-dependent manner (P<0.003). MicroRNA-96 was predicted to bind to the 3'-untranslated regionof VAMP8 mRNA and was detected in platelets. Overexpression of microRNA-96 in VAMP8-expressing cell lines caused a dose-dependent decrease in VAMP8 protein and mRNA, suggesting a role in VAMP8 mRNA degradation. CONCLUSIONS: These findings support a role for VAMP8/endobrevin in the heterogeneity of platelet reactivity, and suggest a role for microRNA-96 in the regulation of VAMP8 expression.
BACKGROUND: Variation in platelet reactivity contributes to disorders of hemostasis and thrombosis, but the molecular mechanisms are not well understood. OBJECTIVES: To discover associations between interindividual platelet variability and the responsible platelet genes, and to begin to define the molecular mechanisms altering platelet gene expression. SUBJECTS/ METHODS: Two hundred and eighty-eight healthy subjects were phenotyped for platelet responsiveness. Platelet RNA from subjects demonstrating hyperreactivity (n=18) and hyporeactivity (n=11) was used to screen the human transcriptome. RESULTS: Distinctly different mRNA profiles were observed between subjects with differing platelet reactivity. Increased levels of mRNA for VAMP8/endobrevin, a critical v-SNARE involved in platelet granule secretion, were associated with platelet hyperreactivity (Q=0.0275). Validation studies of microarray results showed 4.8-fold higher mean VAMP8 mRNA levels in hyperreactive than hyporeactive platelets (P=0.0023). VAMP8 protein levels varied 13-fold among platelets from these normal subjects, and were 2.5-fold higher in hyperreactive platelets (P=0.05). Among our cohort of 288 subjects, a VAMP8 single-nucleotide polymorphism (rs1010) was associated with platelet reactivity in an age-dependent manner (P<0.003). MicroRNA-96 was predicted to bind to the 3'-untranslated regionof VAMP8 mRNA and was detected in platelets. Overexpression of microRNA-96 in VAMP8-expressing cell lines caused a dose-dependent decrease in VAMP8 protein and mRNA, suggesting a role in VAMP8 mRNA degradation. CONCLUSIONS: These findings support a role for VAMP8/endobrevin in the heterogeneity of platelet reactivity, and suggest a role for microRNA-96 in the regulation of VAMP8 expression.
Authors: J P McRedmond; S D Park; D F Reilly; J A Coppinger; P B Maguire; D C Shields; D J Fitzgerald Journal: Mol Cell Proteomics Date: 2003-11-25 Impact factor: 5.911
Authors: Nalini Raghavachari; Xiuli Xu; Amy Harris; Jose Villagra; Carolea Logun; Jennifer Barb; Michael A Solomon; Anthony F Suffredini; Robert L Danner; Gregory Kato; Peter J Munson; Sidney M Morris; Mark T Gladwin Journal: Circulation Date: 2007-03-12 Impact factor: 29.690
Authors: Dmitri V Gnatenko; John J Dunn; Sean R McCorkle; David Weissmann; Peter L Perrotta; Wadie F Bahou Journal: Blood Date: 2002-11-14 Impact factor: 22.113
Authors: C J O'Donnell; M G Larson; D Feng; P A Sutherland; K Lindpaintner; R H Myers; R A D'Agostino; D Levy; G H Tofler Journal: Circulation Date: 2001-06-26 Impact factor: 29.690
Authors: Tong-Tong Li; Susana Larrucea; Shiloe Souza; Suzanne M Leal; José A López; Edward M Rubin; Bernhard Nieswandt; Paul F Bray Journal: Blood Date: 2004-01-22 Impact factor: 22.113
Authors: Serena Fossati; Andrea Baccarelli; Antonella Zanobetti; Mirjam Hoxha; Pantel S Vokonas; Robert O Wright; Joel Schwartz Journal: Epidemiology Date: 2014-01 Impact factor: 4.822
Authors: Srikanth Nagalla; Chad Shaw; Xianguo Kong; Altaf A Kondkar; Leonard C Edelstein; Lin Ma; Junmei Chen; G Stanley McKnight; José A López; Linghai Yang; Ying Jin; Molly S Bray; Suzanne M Leal; Jing-Fei Dong; Paul F Bray Journal: Blood Date: 2011-03-17 Impact factor: 22.113
Authors: Matthew T Rondina; Deepak Voora; Lukas M Simon; Hansjörg Schwertz; Julie F Harper; Olivia Lee; Seema C Bhatlekar; Qing Li; Alicia S Eustes; Emilie Montenont; Robert A Campbell; Neal D Tolley; Yasuhiro Kosaka; Andrew S Weyrich; Paul F Bray; Jesse W Rowley Journal: Circ Res Date: 2019-12-19 Impact factor: 17.367
Authors: Qiansheng Ren; Christian Wimmer; Michael C Chicka; Shaojing Ye; Yi Ren; Frederick M Hughson; Sidney W Whiteheart Journal: Blood Date: 2010-04-30 Impact factor: 22.113
Authors: Lukas M Simon; Leonard C Edelstein; Srikanth Nagalla; Angela B Woodley; Edward S Chen; Xianguo Kong; Lin Ma; Paolo Fortina; Satya Kunapuli; Michael Holinstat; Steven E McKenzie; Jing-Fei Dong; Chad A Shaw; Paul F Bray Journal: Blood Date: 2014-02-12 Impact factor: 22.113